Stay up to date with community and research news.
In a world first, Australian leaders in corneal bioengineering have collaborated to form BIENCO, a consortium that will develop bioengineered eye tissue to treat corneal blindness.
Two teenage siblings with a rare disease have had their vision loss halted and their eye sight improved, after surgery using the world's first approved gene replacement therapy for any inherited blinding eye condition.
Dr Maria Cabrera-Aguas, a researcher at the University of Sydney, Save Sight Institute, explores topics related to eye health and answers some common questions about eye conditions in her new podcast.
The Student Innovation Awards, hosted by the Innovation Hub, recognise University of Sydney students' innovative solutions for real-world impact.
This recent study from the Macular Research Group explored the mechanisms of photoreceptor degeneration, which is found in many blinding diseases such as age-related macular degeneration (AMD).
Macula Month (May) raises awareness about macular degeneration, one of the most common causes of irreversible blindness. We chatted to Professor Mark Gillies, Director of the Save Sight Institute’s Macula Research Group, to find out what macular degeneration is and how research at SSI could help improve treatment options and patient outcomes.
International Day of Women and Girls in Science (11 February) celebrates women in STEM and encourages young women to pursue their passion in science, and other STEM fields. To mark the occasion, we spoke to Pauline Khoo, a PhD student and researcher from the Save Sight Institute and Save Sight Registries about her work, and why she decided to pursue a career in research.
The Professorial Unit at Save Sight is trialling new enhanced 3D microscopes, which allow more precise intraocular surgery in complex cataract, glaucoma, corneal and vitreretinal surgery.
For remote communities, access to health care is often costly and time consuming. With the support of Professor Peter McCluskey, Drs Tharmalingam Mahendrarajah and Nishantha Wijesinghe improved eye health care access by funding OCT machines and implementing medical retina and injection clinics in Top End Indigenous communities.
